Wilson Sonsini Goodrich & Rosati advised Esperto on the transaction. Esperto Medical™ (Esperto), a healthtech start-up specializing in critical care and remote patient monitoring, announced the...
Esperto Medical’s Oversubscribed Series A Financing Round
Bolt Medical’s $900 Million of Acquisition of Boston Scientific
Wilson Sonsini Goodrich & Rosati advised Bolt Medical on the transaction. Boston Scientific (NYSE: BSX) announced it has entered into a definitive agreement to acquire Bolt...
Aadi Bioscience’s $849 Million ADC Deal, $100 Million FYARRO Sale and $100 Million PIPE Financing
Wilson Sonsini Goodrich & Rosati, P.C. is serving as legal counsel to Aadi. McDermott Will & Emery LLP is serving as legal counsel to Kaken. Cooley...
Boston Scientific’s $1.26 Billion Acquisition of Silk Road
Latham & Watkins represented Boston Scientific Corporation in the transaction, and Wilson Sonsini Goodrich & Rosati represented Silk Road Medical. Boston Scientific Corporation (“Boston Scientific”) (NYSE:...
Aspect Biosystems’ $2.7 Billion Collaboration with Novo Nordisk
Wilson Sonsini Goodrich & Rosati advised Aspect Biosystems on the transaction. Aspect Biosystems, a biotechnology company pioneering the development of bioprinted tissue therapeutics, and leading global...